Published in Hepatitis Weekly, April 30th, 2007
"Here, we report a new strategy for HBV DNA vaccine design using a partial gp96 sequence. We linked the N-terminal 1-355aa (N355) of gp96 to HBV genes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.